iRiS Kinetics

IRIS Kinetics develops a label-free biosensing platform for measuring interactions between biological molecules and particles. Its technology is designed for research and development applications involving proteins, nucleic acids, small molecules, bacteria, viruses, and extracellular vesicles. The compact, multiplexed systems measure binding in real time, using IRIS chips that can be prepared with different capture agents to analyze multiple targets in one experiment.

The product range includes the IRIS MX-104 and MX-200 instruments, IRIS chips, and the IRIS TX-100. The company also offers pre-coated, ready-to-use chips and a spotting instrument to help laboratories prepare their own arrays. According to IRIS, the platform supports sensitive measurements, including sub-picogram-per-milliliter protein detection, and can work with samples such as serum and plasma. Its applications include antibody–antigen characterization, small-molecule binding studies, biomarker research, drug development, and immunoassay development. IRIS positions its instruments as an affordable complement or validation tool alongside established SPR and BLI systems, with an emphasis on reliable kinetic measurements and lower-cost consumables.